LXEO
Lexeo Therapeutics Inc.

601
Mkt Cap
$398.51M
Volume
828,104.00
52W High
$10.99
52W Low
$1.45
PE Ratio
-2.02
LXEO Fundamentals
Price
$5.27
Prev Close
$5.46
Open
$5.47
50D MA
$6.79
Beta
1.95
Avg. Volume
777,649.87
EPS (Annual)
-$3.09
P/B
2.48
Rev/Employee
$0.00
$97.57
Loading...
Loading...
News
all
press releases
Lexeo Therapeutics (LXEO) Projected to Post Earnings on Monday
Lexeo Therapeutics (NASDAQ:LXEO) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...
MarketBeat·15d ago
News Placeholder
More News
News Placeholder
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of "Moderate Buy" by Analysts
Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten brokerages that are currently covering the company, Marketbeat...
MarketBeat·18d ago
News Placeholder
Lexeo Therapeutics (NASDAQ:LXEO) Shares Up 10.4% - What's Next?
Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Up 10.4% - Time to Buy...
MarketBeat·21d ago
News Placeholder
Lexeo Therapeutics Highlights FA and PKP2 Cardiac Gene Therapy Progress at Oppenheimer Conference
Lexeo Therapeutics (NASDAQ:LXEO) executives outlined the company's focus on precision medicines for inherited cardiac diseases during a presentation at Oppenheimer's 36th Annual Healthcare Life...
MarketBeat·1mo ago
News Placeholder
Lexeo Therapeutics (NASDAQ:LXEO) COO Jose Manuel Otero Sells 3,016 Shares
Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) COO Jose Manuel Otero sold 3,016 shares of the business's stock in a transaction that occurred on Wednesday, February 18th. The stock was sold...
MarketBeat·1mo ago
News Placeholder
Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 10,173 Shares of Stock
Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Nolan Townsend sold 10,173 shares of the company's stock in a transaction that occurred on Wednesday, February 18th. The shares...
MarketBeat·1mo ago
News Placeholder
Jose Manuel Otero Sells 3,016 Shares of Lexeo Therapeutics (NASDAQ:LXEO) Stock
Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) COO Jose Manuel Otero sold 3,016 shares of Lexeo Therapeutics stock in a transaction on Wednesday, February 18th. The shares were sold at an...
MarketBeat·1mo ago
News Placeholder
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Recommendation of "Moderate Buy" by Brokerages
Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the ten ratings firms that are covering the firm, MarketBeat Ratings reports. One...
MarketBeat·1mo ago
News Placeholder
Lexeo Therapeutics Details FDA Path for LX2006, Highlights LVMI Gains at Guggenheim Biotech Summit
Executives from Lexeo Therapeutics (NASDAQ:LXEO) outlined regulatory plans, clinical data, and manufacturing updates for its lead gene therapy programs during a presentation at Guggenheim's 2026...
MarketBeat·1mo ago
News Placeholder
Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Down 3.2% - Time to Sell?
Lexeo Therapeutics (NASDAQ:LXEO) Trading Down 3.2% - Should You Sell...
MarketBeat·2mo ago
<
1
2
...
>

Latest LXEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.